Chemistry:Fexlamose
From HandWiki
Fexlamose is an investigational new drug that is being developed by Aer Therapeutics for the treatment of chronic obstructive pulmonary disease. It is mucolytic agent that contains a thiol linked to a saccharide that undergoes thiol–disulfide exchange with mucin disulfide bridges thereby breaking those bonds between mucin subunits and reducing the viscosity of mucin.[1][2]
References
- ↑ "Fexlamose". AdisInsight. Springer Nature Switzerland AG. https://adisinsight.springer.com/drugs/800073790.
- ↑ "Mucus as a Treatable Trait in Chronic Airway Diseases". Drugs 86 (4): 443–463. April 2026. doi:10.1007/s40265-026-02294-1. PMID 41712061.
 |  |
